Bank of Montreal Can Grows Stock Position in Doximity, Inc. (NASDAQ:DOCS)

Bank of Montreal Can raised its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 236.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 72,112 shares of the company's stock after purchasing an additional 50,676 shares during the quarter. Bank of Montreal Can's holdings in Doximity were worth $3,850,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Global Retirement Partners LLC raised its position in Doximity by 468.1% in the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock worth $29,000 after buying an additional 440 shares during the last quarter. UMB Bank n.a. lifted its position in Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company's stock valued at $31,000 after purchasing an additional 235 shares during the period. Larson Financial Group LLC boosted its holdings in Doximity by 49.4% in the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company's stock worth $40,000 after purchasing an additional 250 shares during the last quarter. Optimum Investment Advisors bought a new stake in Doximity in the 4th quarter worth approximately $43,000. Finally, Morse Asset Management Inc purchased a new stake in Doximity during the 3rd quarter valued at $46,000. 87.19% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Mizuho upped their price objective on Doximity from $55.00 to $65.00 and gave the company a "neutral" rating in a research report on Monday, February 10th. Wells Fargo & Company reiterated an "equal weight" rating on shares of Doximity in a research note on Friday, February 7th. The Goldman Sachs Group upped their target price on shares of Doximity from $58.00 to $80.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Raymond James reiterated an "outperform" rating and set a $83.00 price target (up previously from $65.00) on shares of Doximity in a research note on Friday, February 7th. Finally, Leerink Partners raised Doximity from a "market perform" rating to an "outperform" rating and raised their target price for the stock from $60.00 to $90.00 in a report on Friday, February 7th. Eleven equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $65.00.

Insider Activity at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the transaction, the director now directly owns 6,360 shares of the company's stock, valued at $366,463.20. This trade represents a 75.87 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 37.40% of the stock is currently owned by insiders.

Doximity Stock Down 3.9 %

NASDAQ DOCS traded down $2.05 during trading on Monday, hitting $51.16. 1,767,347 shares of the stock traded hands, compared to its average volume of 1,984,169. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $85.21. The firm has a 50-day simple moving average of $62.49 and a 200-day simple moving average of $55.97. The company has a market capitalization of $9.55 billion, a P/E ratio of 51.16, a price-to-earnings-growth ratio of 4.10 and a beta of 1.41.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.